PFENYSEPharmaceutical PreparationsFiscal year ends December 31
PFIZER INC
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026
$29.44−0.14 (-0.47%)
Close on Oct 19, 2026
- Market cap
- $167.78B
- P/E (TTM)
- 38.7
- Dividend yield
- 5.84%
Share price
+$4.93 (+20.11%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
PFIZER INC saw revenue fall 0.2% to $63.70B over the twelve months to Jun 28, 2026. Free cash flow was $10.99B, down 11.7% from a year earlier.
Revenue
$63.70B
-0.2% vs. a year earlier
Free cash flow
$10.99B
-11.7% vs. a year earlier
EPS, diluted
$0.76
-59.6% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 28, 2026
Valuation
- Market cap
- $167.78B
- P/E ratio
- 38.7
- Price to sales
- 2.63
- Price to book
- 1.97
- Dividend yield
- 5.84%
- Free cash flow yield
- 6.55%
Fundamentals
- Revenue
- $63.70B
- Net income
- $4.33B
- EPS, diluted
- $0.76
- Free cash flow
- $10.99B
- Book value per share
- $14.95
- Diluted shares
- 5.70B
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$63.70B-0.2% YoY
Gross profit
$46.61B+1.2% YoY
Net income
$4.33B-59.7% YoY
EPS, diluted
$0.76-59.6% YoY
Free cash flow
$10.99B-11.7% YoY
Reported periodTrailing twelve months